Ultra Facial Cream

This formula is fragrance-free, paraben-free, and free from Alcohol Denat, DMDM Hydantoin, and methylisothiazolinone. That is a clean safety profile for a daily leave-on moisturiser. One ingredient worth noting for acne-prone users: Myristyl Myristate, a fatty ester emollient, has moderate comedogenicity data in occlusion studies and may contribute to milia or closed comedones for some skin types. Chlorphenesin is a halogenated co-preservative that appears at a late stage in the formula; it is within accepted limits for leave-on use. No regulatory flags found across EU, India, or Health Canada databases for this ingredient set.

The emollient base is well-structured: Squalane, Apricot Kernel Oil, Avocado Oil, and Sweet Almond Oil are all skin-compatible fats with good evidence for barrier conditioning. Hydroxypalmitoyl Sphinganine is a ceramide precursor that supports the skin's natural barrier lipid cycle, and it appears in the lower portion of the formula where no concentration is publicly disclosed. Pseudoalteromonas Ferment Extract is a marine bioferment with barrier-conditioning activity. This is a heritage formula that is structurally sound and appropriate for its moisturising claim, though the ceramide precursor concentration cannot be independently verified from the ingredient list alone.

The full ingredient list is published on Kiehl's product page. The formula makes no inflated claims and does not use 'clinically proven' or SPF language. The brand does not disclose the concentration of the ceramide precursor, so the functional dose of the key barrier ingredient cannot be publicly verified. Kiehl's states the product is 'dermatologist tested', but no published study with method, sample size, or result is accessible, which means the claim carries partial weight only. The comedogenicity concern from Myristyl Myristate is not mentioned anywhere in product communications.

Kiehl's states 'dermatologist tested' on the product but does not link to or publish a study with lab name, methodology, sample size, or result summary. The full INCI is publicly visible on kiehls.com, which is a baseline transparency positive. No preservative efficacy test result, no stability data, and no clinical performance report are publicly accessible. This places the product in a Grade C evidence category: testing is mentioned, but the details needed to independently evaluate what was tested and what was found are not visible.

Use instructions and frequency guidance are clear on the brand page. Skin type suitability (dry to normal skin) is communicated. The brand does not provide explicit layering guidance for consumers who use multiple actives alongside this moisturiser, which is a common gap. No direct honest caveat about the comedogenicity note for acne-prone users appears on the product page.